Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

from PharmaTalkRadio · host Conference Forum

About this podcast: Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies. For more information, go to IO360summit.com.

Episode metadata supplied by the publisher feed · Published Dec 19, 2025

Embed this episode

Attribution link and audio player

Ready to play

Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

0:00 45:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 45 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on December 19, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this PharmaTalkRadio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!